Definitive Healthcare Corp. (DH)
NASDAQ: DH · Real-Time Price · USD
0.8593
-0.0118 (-1.35%)
At close: May 20, 2026, 4:00 PM EDT
0.8562
-0.0031 (-0.36%)
After-hours: May 20, 2026, 4:10 PM EDT
Definitive Healthcare Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, Definitive Healthcare stock has a consensus rating of "Hold" and an average price target of $2.46. The average 1-year stock price forecast is 186.28% higher than the current stock price, while the lowest is $1.00 (+16.37%) and the highest is $3.50 (+307.31%).
Price Target: $2.46 (+186.28%)
Analyst Consensus: Hold
* Price targets were last updated on Mar 30, 2026.
Analyst Ratings
The average analyst rating for Definitive Healthcare stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 4 | 4 | 3 | 3 | 3 | 2 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 5 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Sell Maintains $2.75 → $1 | Sell | Maintains | $2.75 → $1 | +16.37% | Mar 30, 2026 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $4 → $3 | Hold | Maintains | $4 → $3 | +249.12% | Feb 27, 2026 |
| Stephens & Co. | Stephens & Co. | Hold Maintains $3 → $2 | Hold | Maintains | $3 → $2 | +132.75% | Feb 27, 2026 |
| Barclays | Barclays | Sell Maintains $3 → $2.75 | Sell | Maintains | $3 → $2.75 | +220.03% | Dec 9, 2025 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $5 → $4 | Hold | Maintains | $5 → $4 | +365.50% | Nov 10, 2025 |
Financial Forecast
Revenue This Year
230.29M
from 241.52M
Decreased by -4.65%
Revenue Next Year
230.02M
from 230.29M
Decreased by -0.12%
EPS This Year
0.19
from -1.30
EPS Next Year
0.20
from 0.19
Increased by 5.45%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 236.5M | 243.5M | |
| Avg | 230.3M | 230.0M | |
| Low | 217.8M | 210.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -2.1% | 5.7% | |
| Avg | -4.7% | -0.1% | |
| Low | -9.8% | -8.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.23 | 0.23 | |
| Avg | 0.19 | 0.20 | |
| Low | 0.16 | 0.15 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | 22.3% | |
| Avg | - | 5.5% | |
| Low | - | -22.2% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.